Adaptin Bio (APTN) Retained Earnings (2022 - 2026)

Adaptin Bio's Retained Earnings history runs 5 years deep, the most recent figure standing at -$10.4 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 120.8% year-over-year to -$10.4 million; the TTM figure through Mar 2026 stood at -$10.4 million (down 120.8% YoY), while the FY2025 annual figure was -$9.3 million, down 125.3% from the prior year.
• Retained Earnings came in at -$10.4 million for Q1 2026 at Adaptin Bio, down from -$9.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$27804.0 in Q4 2022 to a low of -$10.4 million in Q1 2026.
• A 5-year average of -$3.6 million and a median of -$2.2 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 3536.99% in 2024 and tumbled 120.8% in 2026, its largest moves.
• Adaptin Bio's Retained Earnings stood at -$27804.0 in 2022, then plunged by 307.84% to -$113397.0 in 2023, then plunged by 3536.99% to -$4.1 million in 2024, then plunged by 125.3% to -$9.3 million in 2025, then slipped by 12.33% to -$10.4 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$10.4 million, -$9.3 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison